Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.65 USD | -3.50% | -3.74% | -37.51% |
Financials (USD)
Sales 2024 * | 777M | Sales 2025 * | 862M | Capitalization | 1.89B |
---|---|---|---|---|---|
Net income 2024 * | 192M | Net income 2025 * | 225M | EV / Sales 2024 * | 2.77 x |
Net Debt 2024 * | 260M | Net Debt 2025 * | 41.48M | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
9.1
x | Employees | 1,761 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.31% |
Latest transcript on Amphastar Pharmaceuticals, Inc.
1 day | -3.50% | ||
1 week | -3.74% | ||
Current month | -11.98% | ||
1 month | -9.80% | ||
3 months | -31.51% | ||
6 months | -18.11% | ||
Current year | -37.51% |
Managers | Title | Age | Since |
---|---|---|---|
Zi Ping Luo
FOU | Founder | 74 | 96-02-28 |
Yong Feng Zhang
CEO | Chief Executive Officer | 77 | 96-02-28 |
William Peters
DFI | Director of Finance/CFO | 56 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Prins
BRD | Director/Board Member | 67 | 03-01-31 |
William Peters
DFI | Director of Finance/CFO | 56 | 14-03-31 |
Director/Board Member | 64 | 01-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.51% | 29 M€ | -6.85% | ||
0.37% | 45 M€ | -2.89% | ||
0.30% | 27 M€ | -7.00% | - | |
0.25% | 1,026 M€ | +6.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 38.65 | -3.50% | 329,460 |
24-04-17 | 40.05 | -2.08% | 494,599 |
24-04-16 | 40.9 | +0.29% | 305,212 |
24-04-15 | 40.78 | +2.93% | 403,717 |
24-04-12 | 39.62 | -1.32% | 392,144 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.51% | 1.89B | |
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.96% | 211B | |
-0.41% | 203B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- AMPH Stock